atorvastatin calcium

This page contains recent news articles, when available, and an overview of atorvastatin calcium but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

atorvastatin calcium
(when available)

Pharmacology and use:
Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor, is used to lower cholesterol and triglycerides in patients with hypercholesterolemia and mixed dyslipidemia and in the treatment of homozygous familial hypercholesterolemia. Atorvastatin has a unique structure, long half-life, and hepatic selectivity, explaining its greater LDL-lowering potency compared to other HMG-CoA reductase inhibitors. For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia.

Mechanism Of Action:
Atorvastatin selectively and competitively inhibits the hepatic enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. As HMG-CoA reductase is responsible for converting HMG-CoA to mevalonate, this results in a decrease in mevalonate, a precursor of cholesterol, and a subsequent decrease in hepatic cholesterol levels and increase in uptake of LDL cholesterol.

News Articles on Atorvastatin

Pfizer-Unilab row reaches retail sector  -  ‎Oct 25, 2009‎
According to the letter, a copy of which was obtained by the Inquirer, Atorvastatin Calcium, the drug Pfizer marketed under the brand Lipitor and which ... Inquirer.net

Pfizer-Unilab row  -  ‎Nov 10, 2009‎
...before the Regional Trial Court in Makati City after Unilab had started selling its generic atorvastatin calcium in August. ... Business Mirror

New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R ...  -  ‎Oct 27, 2009‎
The objective was to study the lipid and anti-inflammatory effects of Slo-Niacin® 1.5 g/day and Lipitor® (atorvastatin calcium) 10 mg/day, given alone and ... Reuters

Pfizer reports 3Q profit rise, revenue drop  -  ‎Oct 20, 2009‎
Such drugs as the pain drug Lyrica (pregabalin) and the cholesterol-lowering drug Lipitor (atorvastatin calcium) had strong sales overseas, but primary-care ... Drug Store News (blog)

Court Report  -  ‎Oct 25, 2009‎
1997) based on Sandoz's filing of an ANDA to manufacture a generic version of Pfizer's Caduet® (atorvastatin calcium -- the active ingredient in ... Patent Docs (blog)

Pfizer Sues Unilab Over Lipitor Drug  -  ‎Oct 23, 2009‎
Pfizer sells the anti-hypertensive drug under the trade name Lipitor, and its generic name is atorvastatin calcium. Pascual said the patent of Lipitor in ... American Chronicle

Brand Names/Synonyms:
atorvastatin calcium is also known by the following brand names and/or synonymsAtorvastatin; Atorvastatin Calcium; Atorvastatin Calcium Salt; Atorvastatin, Calcium Salt; CCRIS 7159; CI 981; Cardyl; HSDB 7039; Lipitor; Sotis; Torvast; Tozalip; Xavator

Drug Category:
atorvastatin calcium is categorized under the following by the FDA: Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA05

Dosage Forms:
Tablets contain 10, 20, or 40mg atorvastatin

Absorption:
Atorvastatin is rapidly absorbed after oral administration. The absolute bioavailability of atorvastatin (parent drug) is approximately 14% and the systemic availability of HMG-CoA reductase inhibitory activity is approximately 30%.

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxy-heptanoicacid





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy